06.01.04
FDA has confirmed that it is in the process of reviewing a petition for a health claim that suggests the consumption of soy protein-based foods may reduce the risk of certain types of cancer, including breast, prostate and colon cancer. The Solae Company, St. Louis, MO, submitted the petition in order to seek approval for the health claim, which focuses on 58 studies supporting the relationship between the consumption of soy protein-based foods and the reduced risk of developing these types of cancer. This careful process and the weight of the scientific evidence led to the decision to file the petition with FDA. Expert researchers from The Solae Company’s Health & Nutrition and Nutraceuticals team were responsible for spearheading the research results on which the petition is based. Several other leading researchers were involved in the scientific review of the data and supported the decision of The Solae Company to file the petition with FDA. External reviewers of the petition included researchers from Harvard University, the University of California Los Angeles Center for Human Nutrition, the University of Illinois at Urbana-Champaign, the University of Arkansas and Wake Forest University.